LINC00654 confers sorafenib resistance by suppressing ferroptosis via STAT3-mediated transcriptional activation of SLC7A11 in Hepatocellular Carcinoma

Huanyan Peng,An Xu,Chao Sun,Fang Tong,Xiaofeng Kang,Huifang Zhou,Jiwen Kang,Xingyu Li,Yuchen Han,Chunyuan Xue,Chuanhao Tang,Liaoxin Fang,Yimeng Du,Juqiang Han,Dianxing Sun

DOI: https://doi.org/10.1016/j.colsurfa.2023.131458

2023-04-15

Abstract:Sorafenib (SRF) is one of the most effective and common multi-kinase targeted therapeutic inhibitors used in advanced hepatocellular carcinoma (HCC). However, the occurrence of SRF resistance remains a major challenge. SLC7A11 is a critical ferroptosis-associated gene, the upregulation of which inhibits ferroptosis in various cancers. However, the mechanisms of SLC7A11 upregulation and the physiological significance of SLC7A11 activation in controlling SRF sensitivity are unclear. Here, we identified a novel lncRNA LINC00654 positively correlates with SLC7A11 expression and predicts poor clinical outcomes in HCC. LINC00654 inhibits HCC cell ferroptosis by altering the levels of Fe 2+ , total ROS, MDA and GSH/GSSG ratio and confers SRF resistance via SLC7A11 expression in HCC cells. Inhibition of LINC00654 or treatment of ferroptosis inducer RSL3 can partly reverse the sensitivity of SRF-resistant cells. Mechanistically, LINC00654 activates SLC7A11 expression by increasing the recruitment of the transcription factor STAT3 onto the SLC7A11 promoter. Furthermore, for the xenograft assay in nude mice, LINC00654/SLC7A11 axis confers SRF resistance, the effect of which can be reversed by LINC00654 knockdown or treatment of RSL3. Clinically, in HCC patients, LINC00654 and STAT3 expression were positively correlated with SLC7A11 expression. Thus, our work established LINC00654/STAT3/SLC7A11 as a vital axis to regulate HCC cell ferroptosis and SRF resistance. Evaluation of the expression of LINC00654 or SLC7A11 in HCC tissue would be an effective way in predicting the efficacy of SRF. Inhibition of LINC00654 or treatment of ferroptosis inducer would be a promising strategy to overcome SRF resistance.

chemistry, physical